
Daily pill slashes 'bad' cholesterol levels by 60% in yearlong trial
Fox News
An experimental daily pill Enlicitide reduced bad LDL cholesterol by 60% in patients with genetic condition, according to a study published in JAMA journal.
Khloe Quill is a lifestyle production assistant with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health.
The trial, led by Dr. Christie M. Ballantyne of the Texas Heart Institute, spanned 59 medical sites across 17 countries.
More Related News













